Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Humanin is an endogenous mitochondrial-derived peptide with reported cytoprotective, neuroprotective, and metabolic effects in preclinical models. It has been studied as a peptide biologic that can improve insulin sensitivity, modulate cellular stress responses, and promote cell survival, but it has not been developed into an approved therapeutic product. Publicly available information indicates that humanin and humanin analogs remain largely research-stage agents, with no active interventional clinical development as a drug; humanin has also appeared in clinical research contexts as a biomarker rather than as an administered therapy. A key limitation to therapeutic development has been its pharmacokinetic profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on humanin.